ARE THERE GENDER SPECIFIC DIFFERENCES IN PATIENT REPORTED OUTCOMES AT INITIATION OF GOLIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS?

被引:0
|
作者
Sholter, D. [1 ]
Bensen, W. G. [2 ,3 ]
Choquette, D. [4 ]
Fortin, I. [5 ]
Arendse, R. [6 ]
Kelsall, J. [7 ]
Sheriff, M. [8 ]
Faraawi, R. [9 ]
Rodrigues, J. [10 ]
Zummer, M. [11 ,12 ]
Dixit, S. [9 ]
Starr, M. [4 ]
Rampakakis, E. [13 ,14 ]
Sampalis, J. S. [13 ,14 ]
Nantel, F. [15 ]
Shawi, M. [15 ]
Otawa, S. [15 ]
Lehman, A. J. [15 ]
机构
[1] Univ Alberta, Edmonton, AB, Canada
[2] St Joseph Hosp, Hamilton, ON, Canada
[3] McMaster Univ, Hamilton, ON, Canada
[4] Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[5] Ctr Rhumatol Est Quebec, Rimouski, PQ, Canada
[6] Univ Saskatchewan, Saskatoon, SK, Canada
[7] Mary Pack Arthrit Ctr, Vancouver, BC, Canada
[8] Nanaimo Reg Gen Hosp, Nanaimo, BC, Canada
[9] McMaster Univ, Hamilton, ON, Canada
[10] Clin Res & Arthrit Ctr, Windsor, ON, Canada
[11] Univ Montreal, Montreal, PQ, Canada
[12] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[13] McGill Univ, Montreal, PQ, Canada
[14] JSS Med Res, Montreal, PQ, Canada
[15] Janssen Inc Canada, Toronto, ON, Canada
关键词
D O I
10.1136/annrheumdis-2014-eular.3979
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AB1044
引用
收藏
页码:1145 / 1145
页数:1
相关论文
共 50 条
  • [31] Patient Evaluations Of Subcutaneous Golimumab Delivery By Autoinjector (SmartJect®) For Treatment Of Rheumatoid Arthritis
    Schulze-Koops, H.
    Giacomelli, R.
    Samborski, W.
    Rednic, S.
    Herold, M.
    Yao, R.
    Govoni, M.
    Vastesaeger, N.
    Weng, H. H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S998 - S999
  • [32] Patient-Reported Outcomes and Their Role in the Assessment of Rheumatoid Arthritis
    Lubeck D.P.
    PharmacoEconomics, 2004, 22 (Suppl 1) : 27 - 38
  • [33] Effects of upadacitinib on patient-reported outcomes in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (01): : E11 - E11
  • [34] Golimumab In the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Oldfield, Vicki
    Plosker, Greg L.
    BIODRUGS, 2009, 23 (02) : 125 - 135
  • [35] REAL-WORLD GOLIMUMAB EFFECTIVENESS AND IMPACT ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR AXIAL SPONDYLARTHRITIS AND A TREATMENT FAILURE TO PREVIOUS TNFI INHIBITOR THERAPY
    Georgiadis, A.
    Theodoridou, A.
    Vounotrypidis, P.
    Zisopoulos, D.
    Kallitsakis, I
    Kandyli, A.
    Migkos, M.
    Bournazos, I
    Sidiropoulos, P.
    Efstathiou, M.
    Athanassiou, P.
    Haratsis, I
    Petrikkou, E.
    Vassilopoulos, D.
    VALUE IN HEALTH, 2019, 22 : S433 - S433
  • [36] Patient adherence with a smartphone app for patient-reported outcomes in rheumatoid arthritis
    Colls, Josh
    Lee, Yvonne C.
    Xu, Chang
    Corrigan, Cassandra
    Lu, Fengxin
    Marquez-Grap, Georgia
    Murray, Meredith
    Suh, Dong H.
    Solomon, Daniel H.
    RHEUMATOLOGY, 2021, 60 (01) : 108 - 112
  • [37] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
    Krueger, Klaus
    Burmester, Gerd R.
    Wassenberg, Siegfried
    Bohl-Buehler, Martin
    Thomas, Matthias H.
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (01) : 131 - 140
  • [38] Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: non-interventional study GO-NICE in Germany
    Klaus Krüger
    Gerd R. Burmester
    Siegfried Wassenberg
    Martin Bohl-Bühler
    Matthias H. Thomas
    Rheumatology International, 2019, 39 : 131 - 140
  • [39] PATIENT REPORTED ADVERSE EVENTS ON RITUXIMAB TREATMENT FOR RHEUMATOID ARTHRITIS
    Visman, I. M.
    Agca, R.
    Voskuiji, A.
    Nurmohamed, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1048 - 1049
  • [40] Patient-reported outcomes of upadacitinib versus abatacept in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (08): : E531 - E531